Fierce Pharma
OCTOBER 7, 2024
After winning a first-in-class nod for its two-drug inhaler Airsupra l | After winning a first-in-class nod for its two-drug inhaler Airsupra last January, AstraZeneca is bolstering the rescue treatment’s clinical package with new data showing it can cut the risk of asthma exacerbations regardless of patients’ disease severity.
MedCity News
OCTOBER 7, 2024
Months before the FTC sued the three largest pharmacy benefit managers, the CEO of Blue Shield of California battled its PBM – CVS Caremark – to bring a lower cost prostate cancer drug to its members. The post Video: Why the FTC’s Lawsuit Against PBMs May Have Some Legs appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
OCTOBER 7, 2024
With a new patent settlement, generic partners Mylan and Natco have cleared one hurdle to a potential U.S. launch of their generic to Novo Nordisk's wildly popular Type 2 diabetes drug Ozempic. | Mylan Pharmaceuticals and Novo Nordisk have reached a confidential settlement in a patent lawsuit tied to generic Ozempic, also known as semaglutide, India’s Natco Pharma said.
MedCity News
OCTOBER 7, 2024
Even top companies struggle to maintain adequate IT staffing levels. Here are several reasons why FQHCs should consider outsourcing to a firm experienced in the nuances of healthcare. The post Why Outsourcing IT and Cybersecurity is the Smart Choice for FQHCs appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
OCTOBER 7, 2024
GSK’s ViiV healthcare unit is countering rival HIV drugmaker Gilead’s recent global access moves with its own pledge to make at least 2 million doses of its long-acting pre-exposure prophylaxis (Pr | The long-acting HIV PrEP maker pledged to make at least 2 million more doses available for low-and middle-income countries in 2025 and 2026.
Pharmaceutical Technology
OCTOBER 7, 2024
The CD7 CAR)-T cell therapy has demonstrated potential in treating patients with relapsed or refractory T-cell leukaemia.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
OCTOBER 7, 2024
Perelel has acquired LOOM, an educational platform for reproductive health, sexual wellness and parenting. Through the acquisition, the company aims to advance health literacy for women. The post Perelel Acquires LOOM to Boost Women’s Health Education in Sexual, Reproductive Health appeared first on MedCity News.
Fierce Pharma
OCTOBER 7, 2024
In this interview, Kavitha Lokesh, Vice President of Global Life Sciences R&D Industry Solutions at Cognizant, discusses her role and the impact of precision medicine. | Kavitha Lokesh, VP of Global Life Sciences R&D Industry Solutions at Cognizant explains how data modernization and AI are key to the shift in personalized medicine, enabling better integration and analysis of diverse health data, enhancing patient care and outcomes.
pharmaphorum
OCTOBER 7, 2024
Victor Ambros and Gary Ruvkun have shared this year's Nobel Prize in Physiology or Medicine for their discovery of microRNA
Fierce Pharma
OCTOBER 7, 2024
After Kaléo unveiled a “redesign” of the in-office commercial team for its EpiPen rival Auvi-Q at the start of the month, the privately held company has announced a fresh round of job cuts in the U | After Kaléo unveiled a “redesign” of the in-office commercial team for its EpiPen rival Auvi-Q at the start of the month, the privately held company has announced a fresh round of job cuts across the U.S.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
OCTOBER 7, 2024
UK Health Secretary Wes Streeting has announced plans to allow NHS England to share primary care data with scientific researchers, taking on some of the responsibility held by GPs. The minister told the Royal College of General Practitioners (RCGP) annual conference that, while many UK patients have given their consent for their data to be shared with studies run by the likes of the UK Biobank, Genomics England, and Our Future Health, they "still see, far too often, that this data is not shared
Pharmaceutical Technology
OCTOBER 7, 2024
The safety review was requested by the French medicines agency, citing new safety reports that alter the risk profile of finasteride.
European Pharmaceutical Review
OCTOBER 7, 2024
New results from a first-of-its-kind study reports that a CAR-T cell therapy provided similar efficacy and safety to relapsed or refractory multiple myeloma patients administered with the treatment in clinical trials. For example, of the 236 patients who received infusions of ciltacabtagene autoleucel (cilta-cel), data shows that 89 percent responded to the treatment.
pharmaphorum
OCTOBER 7, 2024
AstraZeneca pays $100m upfront for rights to an oral lipoprotein(a) drug developed by Chinese biotech CSPC Pharmaceutical.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
PharmaTimes
OCTOBER 7, 2024
Biotech company moves forward with phase 2 trial for precision cancer surgery
PharmaVoice
OCTOBER 7, 2024
Through real-world data, an AI company found that popular weight loss drugs could be a preventive measure for patients at risk of heart attack and stroke.
ALULA
OCTOBER 7, 2024
The Billion-Dollar Question In today's fast-paced business environment, organizational resilience isn't just a buzzword—it's a key driver of success. Consider this: companies with high organizational resilience outperform their peers by an average of 30% in long-term shareholder returns.
PharmaTimes
OCTOBER 7, 2024
Scottish Medicines Consortium recommends pembrolizumab
Referral MD
OCTOBER 7, 2024
Securing Patient Portals: Best Practices for Protecting Online Records 33.33% of patient portals have privacy concerns that create a sense of distrust among many providers and patients. What are the best practices for data security? Most healthcare organizations and other care providers still struggle to find the balance between offering an easy-to-use interface and maintaining data integrity.
MedCity News
OCTOBER 7, 2024
Cardiovascular disease drugs in development intended to reduce lipoprotein (a) are mostly injectable medications, though Eli Lilly also has both oral and injectable drugs in the clinic. AstraZeneca aims to hit that key protein target with an oral small molecule licensed from CSPC Pharmaceutical Group. The post AstraZeneca Expands Cardiovascular Disease Prospects, Paying $100M for Oral Way to Drug Lp(a) appeared first on MedCity News.
pharmaphorum
OCTOBER 7, 2024
A trial of AstraZeneca and Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early after the drug outperformed a standard therapy.The phase 3b BATURA study showed Airsupra (albuterol/budesonide) achieved a statistically significant reduction in the risk of severe asthma exacerbations when used as needed for rescue therapy compared to albuterol on its own.
Pharmaceutical Commerce
OCTOBER 7, 2024
In the final part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Jenni Zilka, SVP, community & specialty pharmacy and president, Good Neighbor Pharmacy, explains how pending legislation can improve patient access, and how these are helping with recognizing pharmacists as HCPs.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
PharmaTech
OCTOBER 7, 2024
The CDMO will be launching its EnzeneX 2.0 continuous manufacturing for biologics technology during CPHI Milan, which is being held Oct. 8–10, 2024 in Milan, Italy.
Healthcare Success
OCTOBER 7, 2024
Influencer marketing is hot! But with all the regulations, can pharmaceutical marketers really utilize influencers to reach consumers and HCPs? The answer is yes! Listen to our latest podcast as Malcolm Bohm, strategic advisor and board member for multiple life sciences companies, reveals how influencer collaborations can transform brand advocacy and audience engagement.
Pharmaceutical Technology
OCTOBER 7, 2024
NP001 is designed to tackle the neurodegenerative disease through an immunologic mechanism as opposed to a neurologic one.
Pharmaceutical Commerce
OCTOBER 7, 2024
The latest news for pharma industry insiders.
Pharmaceutical Technology
OCTOBER 7, 2024
US hedge fund Starboard now holds 0.6% of Pfizer’s value as the drugmaker struggles with its post-pandemic financial performance.
Pharmacy Times
OCTOBER 7, 2024
Eligible patients can receive a 30-day supply of covered drugs and medical supplies that can be renewed every 30 days for as long as an Emergency Prescription Assistance Program (EPAP) is active.
Rep-Lite
OCTOBER 7, 2024
In the sales world, every industry has its unique challenges, and healthcare is no different. Dealing with complex regulations, different product lines, and changing market demands can be overwhelming. However, creating a strong sales strategy in healthcare is crucial because it affects patient care and the adoption of new medical solutions. The healthcare market is large and growing, fueled by technological advancements and an aging population that wants more comprehensive health services.
Pharmacy Times
OCTOBER 7, 2024
Setrusumab could offer a rapid and clinically meaningful decrease in fracture rate in individuals with osteogenesis imperfecta.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
340 
Let's personalize your content